Project Overview: BeaconMRI

BeaconMRI develops a highly magnetized biological material for enhanced MRI scans. Their contrast agent retains potency longer than current options, ensuring successful imaging. Utilizing a "Magnetization Vehicle" based on quantum spin diffusion, their technology is proven in several formulations. The patent-pending innovation shows promising commercial potential. The market sees over 4.2M PET scans annually in the US and Europe. BeaconMRI seeks $7M in funding for development and animal testing within a year. The team includes CEO Itai Katz and Dr. Marcia C. Javitt as Chief Medical Officer. Patient testimonials underscore the technology's lifesaving potential.